Shae Ian Rowlandson, MD | |
263 Farmington Avenue, Farmington, CT 06030-1410 | |
(860) 679-6700 | |
(860) 679-6736 |
Full Name | Shae Ian Rowlandson |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 263 Farmington Avenue, Farmington, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285211219 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 75935 (Connecticut) | Primary |
Entity Name | Windham Community Memorial Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023191467 PECOS PAC ID: 2961309059 Enrollment ID: O20031217000231 |
News Archive
Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
Researchers in the U.S. have discovered a gene mutation that shrivels brain cells which they suspect is responsible for the mental retardation seen in Down syndrome.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate approval of genetic nondiscrimination legislation, House passage of a measure to block implementation of new Medicaid rules and hearings about FDA's need for increased inspection resources in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 1 days ago
Entity Name | Natchaug Hospital, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295811321 PECOS PAC ID: 5395648737 Enrollment ID: O20040202000008 |
News Archive
Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
Researchers in the U.S. have discovered a gene mutation that shrivels brain cells which they suspect is responsible for the mental retardation seen in Down syndrome.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate approval of genetic nondiscrimination legislation, House passage of a measure to block implementation of new Medicaid rules and hearings about FDA's need for increased inspection resources in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 1 days ago
Entity Name | The William W Backus Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467517235 PECOS PAC ID: 0749170645 Enrollment ID: O20040316000739 |
News Archive
Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
Researchers in the U.S. have discovered a gene mutation that shrivels brain cells which they suspect is responsible for the mental retardation seen in Down syndrome.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate approval of genetic nondiscrimination legislation, House passage of a measure to block implementation of new Medicaid rules and hearings about FDA's need for increased inspection resources in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Shae Ian Rowlandson, MD 263 Farmington Ave, Farmington, CT 06030-1921 Ph: (860) 679-2147 | Shae Ian Rowlandson, MD 263 Farmington Avenue, Farmington, CT 06030-1410 Ph: (860) 679-6700 |
News Archive
Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.
Researchers in the U.S. have discovered a gene mutation that shrivels brain cells which they suspect is responsible for the mental retardation seen in Down syndrome.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
Mary Agnes Carey, associate editor of CQ HealthBeat, examines Senate approval of genetic nondiscrimination legislation, House passage of a measure to block implementation of new Medicaid rules and hearings about FDA's need for increased inspection resources in this week's "Health on the Hill from kaisernetwork.org and CQ."
› Verified 1 days ago
William P Shea Iii, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Kristina Frances Victoria Zdanys, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Psychiatry, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Marie Carl Eugene, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Neurology Mc-3835, Farmington, CT 06030 Phone: 860-679-4888 Fax: 860-679-1042 | |
Kelly Nicole Stinson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10 Talcott Notch Rd, Farmington, CT 06032 Phone: 860-679-6700 Fax: 860-679-6736 | |
Feier Liu, D.O Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-6700 Fax: 860-679-6736 | |
Gema Guanco, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 270 Farmington Ave, Suite 309, Farmington, CT 06032 Phone: 860-677-5570 Fax: 860-677-9570 | |
Dr. Asante Kofi Mendes, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2000 |